查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1501131

人乳寡糖（HMO）的全球市场

Human Milk Oligosaccharides (HMO)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 99 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球人乳寡糖(HMO) 市场预计将达到 5.656 亿美元

人乳寡糖(HMO) 的全球市场预计 2023 年为 2.361 亿美元，预计到 2030 年将达到 5.656 亿美元，预测在 2023-2030 年分析期间复合年增长率为 13.3%。婴儿奶粉应用是本报告分析的细分市场之一，预计复合年增长率为 12.9%，到分析期结束时将达到 4.44 亿美元。预计未来七年机能性食品和饮料应用领域的复合年增长率为 17.1%。

美国市场预计6,120万美元，中国预计复合年增长率17.2%

预计 2023 年美国人乳寡糖(HMO) 市场规模将达 6,120 万美元。中国作为世界第二大经济体，预计2030年市场规模将达1.376亿美元，2023年至2030年分析期间复合年增长率为17.2%。其他值得注意的地理市场包括日本和加拿大，预计 2023 年至 2030 年将分别成长 9.2% 和 11.1%。在欧洲，德国的复合年增长率预计约为 10.2%。以澳洲、印度和韩国等国家为首的亚太市场预计到2030年将达到9,230万美元。

2024 年新报告的特点

  • 完全访问影响者参与统计数据
  • 免费存取数位檔案和「MarketGlass」研究平台。我们独特的 MarketGlass 平台以整合和协作的方式汇集了世界各地专家的创造力和市场知识。我们最先进的工具提供世界一流的市场可视性，同时保护参与者的隐私和身分。本报告中提供的数字、统计数据和市场评论是基于该领域专家和影响者共用的经过充分审查的见解。
  • 使用即时资料模拟器工具和客製化报告功能参与互动式调查。
  • 客户全面连结同侪协作互动平台，实现企业间智慧交流
  • 1 年免费报告更新
  • 竞争覆盖范围，包括主要企业的全球市场占有率
  • 多个地区公司的市场影响分析（强/活跃/利基/次要）
  • 访问专家/影响者访谈、播客、新闻公告和活动主题演讲的 YouTube 视频

2024 年世界经济有何预期

货币紧缩以及随之而来的利率上升所带来的地缘政治影响和经济不稳定可能使2024年全球经济动盪。一些因素将继续给復苏之路带来压力，包括中东的敌对行动和日益频繁的气候灾害。儘管存在风险，但一些积极因素正在显现，包括强劲的通货紧缩征兆、缓解对顽固通膨的担忧、供应链正常化以及儘管能源成本出现波动但价格仍趋缓。印度和美国等二十一国集团国家的选举可能会影响资本流动和投资策略。儘管印度作为全球投资目的地的地位日益突出，但在充满活力的人才和资本生态系统的推动下，美国科技公司将继续占据主导地位。儘管该国经济放缓，但由于国内经济富有弹性和有利的法规环境，高科技机会（尤其是硅谷）仍然对寻求高成长潜力的投资者俱有吸引力。欧洲持续应对紧缩的货币政策和景气衰退风险，但英国的前景最严峻，2024 年景气衰退的风险最高。中国仍然是通用凭证，其成长预计将受到政府支出和消费者支出改善的支持。动盪的环境可能为投资者和公司带来机会和挑战。将波动性视为成长的催化剂，并以敏捷性和策略远见来制定投资决策，对于生存仍然至关重要。

受访企业范例（共53家）

  • Basf SE
  • Dextra Laboratories Limited
  • DuPont Nutrition & Health
  • Elicityl SA
  • Glycom A/S
  • Glycosyn LLC
  • Inbiose
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • Nestle Health Science
  • ZuChem, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21988

Global Human Milk Oligosaccharides (HMO) Market to Reach $565.6 Million by 2030

The global market for Human Milk Oligosaccharides (HMO) estimated at US$236.1 Million in the year 2023, is expected to reach US$565.6 Million by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. Infant Formula Application, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$444 Million by the end of the analysis period. Growth in the Functional Food & Beverage Application segment is estimated at 17.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $61.2 Million, While China is Forecast to Grow at 17.2% CAGR

The Human Milk Oligosaccharides (HMO) market in the U.S. is estimated at US$61.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$137.6 Million by the year 2030 trailing a CAGR of 17.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 11.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$92.3 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 53 Featured) -

  • Basf SE
  • Dextra Laboratories Limited
  • DuPont Nutrition & Health
  • Elicityl SA
  • Glycom A/S
  • Glycosyn LLC
  • Inbiose
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • Nestle Health Science
  • ZuChem, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Human Milk Oligosaccharides (HMO) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Functional Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Functional Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Functional Food & Beverage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Food Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Food Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Food Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Human Milk Oligosaccharides (HMO) Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION